What is the relationship between anxiety and thyroid dysfunction?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Relationship Between Anxiety and Thyroid Dysfunction

Patients with anxiety disorders have a significantly increased likelihood of concomitant thyroid dysfunction, and this relationship is bidirectional, with routine thyroid screening recommended when treating anxiety disorders. 1

Key Findings on Comorbidity

The comorbidity between anxiety disorders and thyroid disorders is statistically significant across both population-based and clinical samples, indicating this is not simply due to selection bias in treatment-seeking individuals. 1 This finding has been consistent across studies using varied diagnostic criteria for thyroid dysfunction, including different cut-off values for TSH, T3, T4, and antibodies. 1

Temporal Relationship

  • Age-of-onset data suggests that anxiety disorders typically precede the onset of thyroid disorders in the majority of cases, which may indicate that subtle hypothalamic-pituitary-thyroid (HPT) axis alterations in anxious patients progress over time into subclinical and/or overt thyroid disorders. 1
  • The temporal order supports screening for thyroid dysfunction in patients presenting with anxiety disorders. 1

Mechanisms of Thyroid-Related Anxiety

Hyperthyroidism

Hyperthyroidism precipitates anxiety through direct thyroid hormone effects on brain neurotransmitter systems and widespread activation of peripheral adrenergic receptors, according to the American College of Endocrinology. 2

  • Thyroid hormone receptors are widely expressed throughout the limbic system, directly modulating mood regulation centers. 2
  • The central thyroid system cross-communicates with noradrenergic and serotonergic pathways, disrupting neurochemical balance essential for emotional stability. 2
  • Excess thyroid hormones increase beta-adrenergic receptor sensitivity throughout the body, amplifying sympathetic nervous system activity. 2

Hypothyroidism and Subclinical Hypothyroidism

Both overt and subclinical hypothyroidism are associated with increased anxiety symptoms, with thyroid hormone receptors widely expressed in brain areas involved in mood regulation. 3

  • A diminished TSH response to thyrotropin-releasing hormone (TRH) in subclinical hypothyroidism suggests pituitary dysfunction that may affect brain function. 3
  • Studies demonstrate a negative association between self-reported anxiety levels and TSH in large population samples. 3
  • Both subclinical hypothyroid and subclinical hyperthyroid patients have significantly higher anxiety scores than euthyroid controls. 4

Clinical Presentation Patterns

Resting Thyroid Parameters

  • Patients with panic disorder (PD) and social anxiety disorder (SAD) do not differ from healthy controls in resting thyroid parameters (TSH, T3, T4 measured at single time points). 1
  • This null finding was consistent across studies regardless of standardization of sampling schedules. 1

Stimulated TSH Response

  • Half of studies found evidence for attenuated TSH responses upon stimulation with TRH in patients with anxiety disorders, suggesting subclinical thyroid dysfunction. 1
  • This blunted TSH response indicates subtle HPT axis alterations even when resting parameters appear normal. 1

Anxiety-TSH Relationship

  • There is a negative relationship between self-reported anxiety levels and TSH levels, meaning higher anxiety correlates with lower TSH. 1
  • This relationship was significant even after controlling for smoking status. 1

Prevalence Data

Anxiety prevalence in thyroid disorder patients ranges from 50-63%, with depression prevalence at 42-60%. 5, 6

Risk Factors for Higher Anxiety in Thyroid Patients

  • Female gender (54.9% vs 33.3% in males). 5
  • Lower economic status (73.9% vs 35.5% in higher status). 5
  • Hyperthyroid state (64.1% vs 44.4% in hypothyroid). 5
  • Anxiety symptoms are more severe in overt hypo- and hyperthyroidism compared to subclinical forms. 7

Clinical Implications

Screening Recommendations

Routine screening for thyroid disorders is recommended when treating patients with anxiety disorders, as supported by multiple professional societies. 1

  • Thyroid function testing should be considered in patients presenting with new or worsening anxiety, especially middle-aged patients with mood disturbances or cognitive complaints. 3
  • When evaluating altered mental status with anxiety symptoms, clinicians should consider subclinical hypothyroidism in the differential diagnosis. 3

Treatment Outcomes

Restoration of euthyroidism is accompanied by improvement in quality of life and psychological symptoms in patients with overt hypothyroidism, subclinical hypothyroidism, and overt hyperthyroidism. 7

  • The overt hyper- and hypothyroidism groups show more improvement than subclinical groups after treatment. 7
  • Management of thyroid disorders should incorporate treatment of anxiety and depression, with routine psychiatric screening advisable. 5

Important Clinical Caveats

  • The nature (hypothyroidism vs. hyperthyroidism) and severity (subclinical vs. overt) of comorbid thyroid disorders often remains unclear in clinical practice, as studies rarely report these details systematically. 1
  • Part of the observed comorbidity may be due to simultaneous presence of mood disorders, which are highly co-occurring with generalized anxiety disorder. 1
  • Overlap of symptoms common to both thyroid dysfunction and anxiety (palpitations, tremor, sweating, fatigue) is an important limitation when making clinical assessments. 4
  • Stress-related long-term alterations in the hypothalamic-pituitary-adrenal (HPA) axis may foster autoimmunity and contribute to shared etiopathogenetic mechanisms between anxiety and thyroid dysfunction. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Pathophysiological Mechanisms of Anxiety in Hyperthyroidism, Myocardial Infarction, and Pheochromocytoma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Subclinical Hypothyroidism and Mental Status Changes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Anxiety and Depression among Patients with Thyroid Function Disorders.

Journal of Nepal Health Research Council, 2020

Research

Prevalence of anxiety and depressive symptoms among patients with hypothyroidism.

Indian journal of endocrinology and metabolism, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.